Work

Decision regret and toxicity perception following adjuvant pembrolizumab in renal cell carcinoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4512

Authors: Elizabeth Nally, Veda Kudva, Gina Sherpa, Yifan Wang, Federica Sordelli, Giuseppe Basile, Sara Coca Membribes, Catherine Graham, Francesca Jackson-Spence, Bernadett Emma Szabados, Naveed Sarwar, Axel Bex, Antonio Rullan, Thomas Powles

Institutions: Barts Cancer Institute, The Royal Free Hospital, Imperial College Healthcare NHS Trust, Queen Mary University of London, Royal Free London NHS Foundation Trust, University College London, Cancer Research UK

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162554521

Cites:

Cited by: 1

Related to: